Personal tools

MCL coexpression mm9:2122

From FANTOM5_SSTAR

Revision as of 16:16, 10 October 2012 by Autoedit (talk | contribs) (Created page with "{{MCL_coexpression_mm9|gostat_on_MCL_coexpression=GO:0033791;3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity;0.00635511970634964;93732!GO:00039...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search


Phase1 CAGE Peaks

 Short description
Mm9::chr14:9090551..9090576,-p7@Acox2
Mm9::chr14:9090582..9090612,-p8@Acox2
Mm9::chr14:9091805..9091827,-p5@Acox2
Mm9::chr6:86715860..86715915,-p2@Anxa4


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:00337913alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity0.00635511970634964
GO:0003997acyl-CoA oxidase activity0.0105907055519834
GO:0016725oxidoreductase activity, acting on CH or CH2 groups0.0105907055519834
GO:0016634oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor0.0127078020996407
GO:0006635fatty acid beta-oxidation0.015879529810854
GO:0003995acyl-CoA dehydrogenase activity0.015879529810854
GO:0005544calcium-dependent phospholipid binding0.015879529810854
GO:0019395fatty acid oxidation0.015879529810854
GO:0016627oxidoreductase activity, acting on the CH-CH group of donors0.0296239153511649
GO:0016324apical plasma membrane0.0310991397017297
GO:0050660FAD binding0.0340323921568733
GO:0001822kidney development0.034869854506458
GO:0045177apical part of cell0.034869854506458
GO:0001655urogenital system development0.034869854506458
GO:0042579microbody0.034869854506458
GO:0005777peroxisome0.034869854506458
GO:0050662coenzyme binding0.04322773381055



Relative expression of the co-expression cluster over median <br>Analyst:



"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}